Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novocure Ltd NVCR

Healthcare Medical Devices
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and... see more

Recent & Breaking News (NDAQ:NVCR)

INVESTOR REMINDER: Berger Montague Advises NovoCure Limited (NVCR) Investors to Inquire About a Securities Fraud Class Action by August 18, 2023

Newsfile July 6, 2023

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire July 6, 2023

NVCR INVESTOR NOTICE: NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile July 5, 2023

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile July 5, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire July 5, 2023

ROSEN, SKILLED INVESTOR COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

Newsfile July 4, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

PR Newswire July 3, 2023

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile July 3, 2023

NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action - Contact Lieff Cabraser

Business Wire July 3, 2023

Novocure to Report Second Quarter 2023 Financial Results

Business Wire July 3, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire July 3, 2023

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

PR Newswire July 1, 2023

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire July 1, 2023

NOVOCURE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NovoCure Limited - NVCR

PR Newswire June 30, 2023

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of NovoCure Limited (NVCR) Investors and Encourages Investors to Contact the Firm Before August 18, 2023

Business Wire June 30, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire June 30, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile June 30, 2023

ROSEN, National Trial Lawyers, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR

Newsfile June 29, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

Newsfile June 29, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile June 29, 2023